Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion type Assertion NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_head.
- NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion description "[We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_provenance.
- NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion evidence source_evidence_literature NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_provenance.
- NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion SIO_000772 16114055 NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_provenance.
- NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion wasDerivedFrom befree-20140225 NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_provenance.
- NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_assertion wasGeneratedBy ECO_0000203 NP268121.RAd_s7ETGgp0kG21W_QcNjXlTwbHJ-PhkO6TkyYYRULeQ130_provenance.